Skip to main content
OpenTrials
Completed

NCT Number: NCT01112228

Clinical Staging Tools for the Impacts of Obesity on Individuals

This study will assess various published staging tools to assess the health impacts of obesity on individuals. The aim is to identify benefits and drawbacks, and thus help Obesity Centres and GPs better assess obese individuals as well as better identify who benefits most from having weight loss treatment.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Morbid Obesity Body Weight Nutrition Disorders Nutritional and Metabolic Diseases Obesity Obesity, Morbid Overnutrition Overweight Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

16 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Imperial Weight Centre, Imperial College London

London, United Kingdom

About this study

This study will assess various published staging tools to assess the health impacts of obesity on individuals. The aim is to identify benefits and drawbacks, and thus help Obesity Centres and GPs better assess obese individuals as well as better identify who benefits most from having weight loss treatment

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Morbid obesity
  • At least 1 year follow-up after bariatric surgery

Exclusion criteria

  • N/A

Treatment and study plan

bariatric surgery

Procedure

Bariatric surgery: Gastric bypass, Sleeve gastrectomy, or Gastric banding

Primary outcomes

  1. Changes in Obesity Scores After Weight Loss Treatment

    Time frame: Minimum of 1 year follow-up

    Changes were measured in the following clinical domains

    -Airway, Body Mass Index, Cardiovascular risk, Diabetes, Economic, Functional. Gonadal, Body Image.

    An improvement was considered when any 1 of these domains changes for the positive. Thus, if a patient had an improvement in cardiovascular risk the intervention was considered beneficial even if no other domains changed.

    Out measure is calculated as the count of participants achieving at least 1 improvement (Count)

Secondary outcomes

  1. Changes in Obesity Scores in Various Subgroups

    Time frame: Minimum of 1 year follow-up

    Changes in obesity scores in patients with carious co-morbid conditions (eg, type 2 diabetes, sleep apnoea) before bariatric surgery

Sponsors and collaborators

Lead sponsor

Imperial College London

Other

Registry information

Official study title

Assessing Clinical Staging Tools for Tracking the Impacts of Obesity on Individuals

Acronym: COST

Important dates

Study start
2009
Primary completion
2011
Study completion
2011
First posted
Apr 28, 2010
Registry last updated
Oct 27, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.